Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.

J Autoimmun · 2020 · PMC7365106 · PMID 32690352

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend towards significancep = 0.06so close (0.05 < p ≤ 0.1)

The inclusion of age and confusion (not included in the initial model due to the number of cases lost), do not modify the independent association between mortality and comorbidity – Charlson index; BCRSS response remained protective with a trend towards significance (adjusted OR 0.039, p = 0.06).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.